Vasodilator Therapy for Decompensated Heart Failure**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 52, Issue 3, 2008, Pages 208-210

  Yancy, Clyde W ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDRALAZINE; ISOSORBIDE DINITRATE; NESIRITIDE; NITROPRUSSIDE SODIUM;

CONGESTIVE HEART FAILURE; DIURETIC THERAPY; EDITORIAL; FOLLOW UP; HEART FAILURE; HEART OUTPUT; HEMODIALYSIS; HEMODYNAMICS; HUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT INDICATION; VASCULAR RESISTANCE;

CARDIOTONIC AGENTS; HEART FAILURE; HEMODYNAMICS; HUMANS; NATRIURETIC PEPTIDE, BRAIN; NITROPRUSSIDE; STROKE VOLUME; VASODILATOR AGENTS;

EID: 46249111634     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.03.046     Document Type: Editorial

References (17)

1. Nitroprusside (Systemic) Drugs.com [online database]. http://www.drugs.com/mmx/nitroprusside-sodium.html Accessed February 25, 2008
2. RxList: The Internet Drug Index. http://www.rxlist.com/cgi/generic/nitroprusside_cp.htm Accessed February 25, 2008
3. Mullens W., Abrahams Z., Francis G.S., et al. Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 52 (2008) 200-207
4. Taylor A.L., Ziesche S., Yancy C.W., et al. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial. Circulation 115 (2007) 1747-1753
5. Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 (2006) e1-e2
6. Publication Committee for the VMAC (Vasodilatation in the Management of Acuity CHF) Investigators. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial (erratum in JAMA 2002;288:577). JAMA 287 (2002) 1531-1540
7. Sackner-Bernstein J.D., Kowalski M., Fox M., and Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 293 (2005) 1900-1905
8. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
9. Gheorghiade M., Konstam M.A., Burnett Jr. J.C., et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA 297 (2007) 1332-1343
10. Konstam M.A., Gheorghiade M., Burnett Jr. J.C., et al., EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297 (2007) 1319-1331
11. Cohn J.N., and Burke L.P. Nitroprusside. Ann Intern Med 91 (1979) 752-757
12. Stevenson L.W. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant 10 (1991) 468-476
13. Elliott W.J. Management of hypertension emergencies. Curr Hypertens Rep 5 (2003) 486-492
14. Popovic Z.B., Khot U.N., Novaro G.M., et al. Effects of sodium nitroprusside in aortic stenosis associated with severe heart failure: pressure-volume loop analysis using a numerical model. Am J Physiol Heart Circ Physiol 288 (2005) H416-H423
15. Gheorghiade M., Filippatos G., De Luca L., and Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 119 (2006) S3-S10
16. Gheorghiade M., Zannad F., Sopko G., et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112 (2005) 3958-3968
17. Binanay C., Califf R.M., Hasselbad V., et al., ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: the ESCAPE trial. JAMA 294 (2005) 1625-1633